View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
Modality Solutions|24 February 2016

Cold Chain Logistics with Transport Validation

Transportation hazards affect drug product quality and efficacy.

Modality Solutions designs and validates cold chain controlled environment logistics solutions.

Transportation hazards affect drug product quality and efficacy.

You have to understand their impact. A range of environmental and operational conditions can influence drug product integrity during the transport process from point-of-manufacturer to point-of-distribution and finally to the patient at point-of-use:

• Exposure to extreme weather such as heatwaves, rain, or snow • Packaging degradation • Courier mishandling • Import / export requirement delays • Transit time and transit storage conditions

Regulatory scrutiny to ensure patient safety for all drug products for a global supply chain process requires a robust validation master plan to show that stress during transport does not impact drug product quality, reduce shelf life, or impacts patients’ safety. EMEA and FDA required elements for cold chain validation master plan:

• Packaging qualification • Drug product characterization • Transport validation • Validation summary report

All these elements have to be fully integrated and well documented in your quality system prior to regulatory submission. We expect the scrutiny on the cold chain that has challenged many new biopharmaceuticals – including immunotherapies and biosimilars – to continue to delay and frustrate the submission process unless the manufacturer is properly prepared. The regulators are better versed on the potential dangers and have seen best practices in cold chain for years.

Competing priorities, changing expectations, cost pressures, sustainability initiatives, emerging markets - these are some of the challenges facing cold chain management professionals every day. Solutions...
Regenerative medicine is a novel biomolecular approach to exciting new clinical therapies. Generally, this grouping involves three major therapy applications: cell therapies or stem cell...
Immunomedics ( is a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer.
Bristol-Myers Squibb (BMS) is a global biopharmaceutical company headquartered in New York City that specialises in discovering, developing and delivering innovative medicines for patients with...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology